Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020
Corporate Participants:
Bruce Voss — Investor Relations
Michael W. Nall — President and Chief Executive Officer
Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations
Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director
Analysts:
Jason McCarthy — Maxim Group — Analyst
Sally Yanchus — Brookline Capital Markets — Analyst
____
To read the full earnings call transcript, click here.
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
Listen On
